ESC Premium Access

Hot Line preventive strategies 2

Event: ESC CONGRESS 2016
Topic: Miscellaneous
Session type: Hot Line
Date: 30 August 2016
Time: 14:00 - 15:30


12 presentations in this session

ENSURE-AF study: Edoxaban for cardioversion of atrial fibrillation

Speaker: Professor A. Goette (Paderborn, DE)

ENSURE-AF - Discussant review

Speaker: Doctor R. Cappato (Milan, IT)

ENSURE-AF - Panel discussion


ANNEXA-4 - Andexanet alfa for reversal of Factor Xa inhibitors in patients with acute major bleeding

Speaker: Doctor S. Connolly (Hamilton, CA)

ANNEXA-4 - Discussant review

Speaker: Professor G. Lip (Liverpool, GB)

ANNEXA-4 - Panel discussion


REVERSE II - Multi-national validation of the men continue and HERDOO2 rule to identify low risk unprovoked venous thromboembolism patients who can discontinue anticoagulants

Speaker: Doctor M. Rodger (Ottawa, CA)

REVERSE II - Discussant review

Speaker: Professor G. Agnelli (Perugia, IT)

REVERSE II - Panel discussion


YEARS - Safety and efficiency of a simplified diagnostic management algorithm for 3500 patients with clinically suspected acute pulmonary embolism

Speaker: Doctor T. van der Hulle (The Hague, NL)

8 speakers from this session

Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)
30 presentations
0 follower

Doctor Riccardo Cappato

Humanitas Research Hospital, Milan (Italy)
12 presentations
0 follower

Doctor Stuart J Connolly

Population Health Research Institute, McMaster University, Hamilton (Canada)
10 presentations
0 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
64 presentations

Doctor Marc Rodger

The Ottawa Hospital, Ottawa (Canada)
1 presentation
0 follower

Professor Giancarlo Agnelli

, Perugia (Italy)
8 presentations
0 follower

Doctor Tom van der Hulle

, The Hague (Netherlands (The))
1 presentation
0 follower

Professor Marion Delcroix

University Hospitals (UZ) Leuven, Leuven (Belgium)
9 presentations
0 follower

This platform is supported by

logo Novo Nordisk